Archives

img-01

China expands medical device MAH program

Several years after it piloted a MAH system for medical devices in 4 locations in China, the government is expanding the pilot to 21 provinces/municipalities. The expanded Medical Device Marketing Authorization Holder (MAH) program will offer scientists and pharmaceutical research and development institutions... Read More

img-01

New drug applications on rise in China

With clinical research and regulatory filings booming in China, regulatory authorities are receiving a record number of drug applications for new clinical trials and drug approvals. Last year, more than 5,500 applications for technical review were filed with China’s Center for Drug... Read More

img-01

Medical device registrations in China down precipitously

Registrations of new medical devices dropped sharply in China last year, with the overall level of registration activity down to its lowest level since China started publishing registration data six years ago. Initial registrations of medical devices with China’s National Medical Products Administration (NMPA)... Read More